MANZO MICHAEL P. 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Feb 19, 2020
Insider Transaction Report
Form 4
MANZO MICHAEL P.
Vice President of Engineering
Transactions
- Award
Common Stock
2020-02-14+7,500→ 18,421 total - Award
Stock Option (right to buy)
2020-02-14+7,500→ 7,500 totalExercise: $6.55Exp: 2030-02-14→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on February 1, 2021, and the remaining balance will vest monthly on the first day of each calendar month thereafter for a period of two years.
- [F2]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 1, 2021, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.